Zealand Pharma A/S/ADR

Over the past 90 days, Zealand Pharma A/S (ZLDPF) has recorded zero cyber incidents and zero red-flag 8-K filings related to bankruptcy, delisting, restatement, or officer departures. This clean near-term record provides a baseline, though low signal in a 90-day window does not preclude structural risks—particularly in biotech where financing events and equity dilution cycles drive longer-term shareholder value. The full $49 Report extends analysis to 12 months of SEC filings, calculates dilution risk scores, contextualizes any financing history and capital raises, and flags AI-detected risk signals that precede formal disclosures. The full $49 Report adds dilution trajectory, 12-month red-flag context, and forward-looking risk scoring.